The function of long non-coding RNA IFNG-AS1 in autoimmune diseases

0Citations
Citations of this article
1Readers
Mendeley users who have this article in their library.
Get full text

Abstract

The prevalence of autoimmune diseases ranks as the third most common disease category globally, following cancer and heart disease. Numerous studies indicate that long non-coding RNA (lncRNA) plays a pivotal role in regulating human growth, development, and the pathogenesis of various diseases. It is more than 200 nucleotides in length and is mostly involve in the regulation of gene expression. Furthermore, lncRNAs are crucial in the development and activation of immune cells, with an expanding body of research exploring their association with autoimmune disorders in humans. LncRNA Ifng antisense RNA 1 (IFNG-AS1), a key regulatory factor in the immune system, also named NeST or TMEVPG1, is proximally located to IFNG and participates in the regulation of it. The dysregulation of IFNG-AS1 is implicated in the pathogenesis of several autoimmune diseases. This study examines the role and mechanism of IFNG-AS1 in various autoimmune diseases and considers its potential as a therapeutic target.

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Zhao, J., Gui, Y., Wu, W., Li, X., Wang, L., Wang, H., … Yuan, C. (2024, September 1). The function of long non-coding RNA IFNG-AS1 in autoimmune diseases. Human Cell. Springer. https://doi.org/10.1007/s13577-024-01103-9

Save time finding and organizing research with Mendeley

Sign up for free